Bionime Corporation
4737.TW
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.25B
Close$
Share Statistics
| Market cap | $4.25 Billion |
|---|---|
| Enterprise Value | $6.64 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.65 |
| Beta | -0.12 |
| Outstanding Shares | 78,470,000 |
Return
| Return on Equity | -13.58% |
|---|---|
| Return on Assets | -5.05% |
| Return on Invested Capital | -9.21% |
Valuation & Multiples
| P/E Ratio | -13.65 |
|---|---|
| PEG | -5.2 |
| Price to Sales | 2.62 |
| Price to Book Ratio | 2.12 |
| Enterprise Value to Revenue | 3.87 |
| Enterprise Value to EBIT | -20 |
| Enterprise Value to Net Income | -24 |
| Total Debt to Enterprise | 0.42 |
| Debt to Equity | 1.32 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$0.20
Average shareholder expectationRevenue Estimate
$445.15 M
Average shareholder expectationNext Earnings Call
Expected Date
November 6, 2026
EPS Estimate
$0.20
Average shareholder expectationRevenue Estimate
$445.15 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bionime Corporation
1,111 employees
CEO: Chun-Mu Huang Bionime Corporation, headquartered in Taichung, Taiwan, specializes in the development, production, and global distribution of medical instruments. The company maintains a significant international presence, serving markets in countries ...